Epiminder Announces Publication of Landmark Clinical Trial Confirming Safety and Efficacy of the Minder® System
By API User
First clinical trial published demonstrating safety and efficacy of a bilateral continuous EEG monitoring system Clinically relevant findings were identified in 88% of patients High-quality, durable EEG signals comparable to standard of care scalp monitor MELBOURNE, Australia & DALLAS–BUSINESS WIRE– Epiminder, a pioneer in implantable continuous EEG monitoring (iCEM™), today announced the publication of results … Continued